Good morning! Another health care case comes to the Supreme Court today. See my preview below, and keep an eye out for more coverage later today. STAT's ...
Alembic Pharmaceuticals announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Olopatadine Hydrochloride ...